RECAP Journal Club

Lizzy, Susannah and Sam reflect on the study's strengths and limitations, before discussing the broader implications of the study for regional, rural and remote communities across Australia.

Lizzy, Susannah and Sam unpack the study design, discussing the methods used and walking through the key findings of the study.

Lizzy, Susannah and Sam introduce the study, exploring why it was conducted, who took part and how participants were recruited. Host: Dr Sam Harris - Medical Oncologist, Bendigo Health Cancer Centre; Regional Oncology Lead, VCCC Alliance Authors in the room: Dr. Lizzy Johnston - Group Lead, Cancer Survivorship, Cancer Council Queensland Dr. Susannah Ayre- Post Doctoral Research Fellow, Cancer Coun...

BONUS AUDIENCE Q + A. Featuring Shivanshan and Sally and moderated by A/Prof Christopher Steer.

Sally discusses the strengths, limitations and impacts of the Nurse Navigator model.

Dr. Shivanshan Pathmanathan, Medical Oncologist and Geriatric Oncology Lead at Townsville Cancer Centre Queensland, and Sally discuss their paper, "Providing early access to geriatric oncology services in a regional cancer centre - A two-year experience in the establishment of a Geriatric Oncology Nurse Navigator Model".

Sally Allen provides important context around her role as Nurse Navigator (Cancer Services) Clinical Nurse Consultant at Townsville Cancer Centre. Hosted by Associate Professor Christopher Steer, Medical Oncologist at Border Medical Oncology at the Albury Wodonga Regional Cancer Centre in regional NSW, Australia.

A/Prof Oliver Klein discusses the real-world application of the trial, and future directions for rare cancers and immunotherapy in regional Australia.

A/Prof Oliver Klein takes us through an outline of the different cohorts, alongside the key findings and results from the trial.

A/Prof Oliver Klein provides a high-level overview of the trial's background, design, intervention and methods.

DYNAMIC III Professor Tie shares insights into the upcoming DYNAMIC III study, how it differs from DYNAMIC II, and what future research may mean for the evolution of personalised cancer care in regional settings.

Clinical Implications and Rural Applicability Professor Tie explores how the trial results translate into real-world clinical practice, including patient selection, access to ctDNA testing, and considerations for regional and rural settings.

Key Findings Professor Tie discusses the key findings of the DYNAMIC trial, and what these results mean for clinical decision-making and patient care.

Background, Context and Trial Design Professor Tie outlines the background and clinical context of the DYNAMIC trial, and explains the rationale, design, and methods underpinning the study.